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Abstract
Introduction: The burden of musculoskeletal disorders increases every year, with low back and neck pain being
the most frequently reported conditions for seeking manual therapy treatment. In recent years, manual therapy
research has begun exploring the dose-response relationship between spinal manipulation treatment characteristics
and both clinical and physiological response to treatment.
Objective: The purpose of this scoping review was to identify and appraise the current state of scientific knowledge
regarding the effects of spinal manipulation frequency and dosage on both clinical and physiological responses.
Methods: A scoping review was conducted to identify all available studies pertaining to our research question.
Retrieved papers were screened using a 2-phase method, a selective sorting with titles and abstracts. Potentially
relevant studies were read, and data was extracted for all included studies. Randomized control trials were assessed
using the Cochrane Risk of Bias Tool for quality assessment.
Results: The search yielded 4854 publications from which 32 were included for analysis. Results were sorted by dosage
or frequency outcomes, and divided into human or animal studies. Animal studies mainly focused on dosage and
evaluated physiological outcomes only. Studies investigating spinal manipulation dosage effects involved both human
and animal research, and showed that varying thrust forces, or thrust durations can impact vertebral displacement,
muscular response amplitude or muscle spindle activity. Risk of bias analysis indicated only two clinical trials assessing
frequency effects presented a low risk of bias. Although trends in improvement were observed and indicated that
increasing the number of SM visits in a short period of time (few weeks) decreased pain and improve disability, the
differences between the studied treatment frequencies, were often not statistically significant and therefore
not clinically meaningful.
Conclusion: The results of this study showed that SM dosage and frequency effects have been mostly studied over
the past two decades. Definitions for these two concepts however differ across studies. Overall, the results showed
that treatment frequency does not significantly affect clinical outcomes during and following a SM treatment period.
Dosage effects clearly influence short-term physiological responses to SM treatment, but relationships between these
responses and clinical outcomes remains to be investigated.
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Introduction
Musculoskeletal disorders represent a major public
health issue. According to the 2016 Global Burden of
Diseases Study, back and neck pain rank among the top
five disorders with regard to years lived with disability,
and the related expenses increase every year [1].
Disability-Adjusted Life Years (DALYs) associated to low
back and neck pain keep rising every decade, with an es-
timated increase of about 30 million people affected be-
tween 1990 and 2016. Moreover, a recent special issue
published in the Lancet highlighted the fact that disabil-
ity related to low back pain is projected to increase in
low-income and middle-income countries, where re-
sources and quality healthcare are limited, but also
where back and neck have been far less studied [2].
Several evidence-based practice guidelines for back
and neck pain management have been published in the
last decade [3–6]. They clearly highlight the complex na-
ture of back and neck pain clinical management while
providing guidance and potential care pathways for
patients-clinicians shared decision-making. Although
most of these recent guidelines are based on low to
moderate evidence, the vast majority of them suggests
that conservative treatments, including manual therap-
ies, are effective options to treat acute, subacute, and
chronic spinal disorders.
Manual therapies are used by many professionals
around the world. Among these therapies, chiropractic
is widely used. And according to Beliveau et al., low back
pain (49,7%) is the first complaint that drives patients to
chiropractic offices, followed by neck pain (22,5%) and
extremity disorders (10%) [1, 7]. Spinal manipulation
(SM) is defined as a thrust of high velocity and low amp-
litude delivered to the spine using a specific contact in
order to provide mobility to a joint [8]. It is the most
common tool used by chiropractors to treat patients as
79% reported using this treatment modality on a regular
basis [7]. Although current evidence suggests that SM
can yield positive clinical outcomes such as reducing
pain and disability, current knowledge regarding the
underlying mechanisms leading to such clinical re-
sponses is scarce [3, 4].
From a medial perspective, the effectiveness of a treat-
ment is commonly contingent on the patient’s compliance
and persistence, which are characterized by the patient ad-
herence to the treatment prescription. The prescription is
first defined by the treatment dosage. Dosage conditions
the response or the pattern of the physiological response,
for which there is a threshold defining the lower and
higher dosages that can be prescribed to have a positive
effect and to avoid an adverse event [9]. The prescription
is also defined by the dose frequency, which is the number
of times a substance is administered within a specific time
period or the number of doses administered over a
specific time interval. Prescription, however, is not a con-
struct commonly used within the context of SM.
Recent studies have showed that SM physiological and
biomechanical effects can be characterized based on SM
force-time profiles using biomechanical parameters such
as thrust force, preload force, thrust duration and rate of
force application [10]. However, the relation between dose,
frequency and treatment outcome remains unknown.
Moreover, there is no known standard regarding the
number of SM treatments that should be administered
in the management of a given condition. In clinical prac-
tice, the frequency of treatments depends mostly on the
clinician’s personal experience. Chiropractors adapt their
treatments according to the patients’ symptoms presen-
tation. In fact, their treatments are modulated based on
the individual’s conditions and symptoms as well as their
also response to treatments. Despite the number of stud-
ies published in the past few years trying to define SM
treatments focusing on physiological effects of variable
dose on animals or variable frequency in human, there is
a lack of evidence regarding how many SM treatments
over a given period are required and what dosage should
be used.
The purpose of this scoping review is therefore to
evaluate the current state of scientific knowledge regard-
ing the effect of SM frequency and dosage on both clin-
ical and physiological responses. Specifically, the primary
objective is to identify all clinical and physiological out-
comes specific to SM frequency and dosages effects. The
secondary objective is to report on the clinical and
physiological effects of frequency and dosages. The third
objective is to document all adverse events.
Methods
A scoping review was chosen as the most appropriate
methodology to answer such a broad research question
and capture the breadth of information on a topic that
has been studied through diverse and heterogeneous de-
signs. It identifies gaps in current knowledge in order to
inform future research studies. This scoping review was
based on the framework from Levac et al. using a 5-step
method review [11].
Step 1: identifying the research question
This scoping review was conducted to answer the fol-
lowing research question: what is the current state of
scientific knowledge regarding the effect of SM treat-
ment frequency and dosage on both clinical and physio-
logical responses?
Step 2: identifying relevant studies
The search strategy was developed in collaboration with
a university librarian and conducted using the following
databases: MEDLINE, CINAHL (Cumulative Index to
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Nursing and Allied Health Literature), ICL (Index to
Chiropractic Literature), MANTIS (Manual, Alternative
and Natural Therapy Index System) and Cochrane Cen-
tral Register of Controlled Trials. Databases were
searched from inception up to September 2017. A com-
bination of the following indexing terms (MESH or
non-MESH) relevant to our research theme was used:
musculoskeletal manipulation, dose-response or dosage,
and frequency. The authors also searched for additional
data sources from google scholar, conference abstracts
and proceedings, references from unpublished data, and
book chapters. An Endnote (version X8.2, Clarivate Ana-
lytics©, Boston MA, USA) library was created to import
all search results and remove any duplicates.
Step 3: study selection
Inclusion and exclusion criteria
To be included, the studies had to be published in a
peer-reviewed journal and written in English, French or
Spanish language. We considered for inclusion
human-based studies (without any age limits) and stud-
ies involving animal models. Studies also had to involve
any form of SM (including mobilization) as well as a
modulation and a quantification of at least one param-
eter of treatment frequency or dosage. All included stud-
ies had to match the following operational definitions
for frequency and dosage:
1) SM dosage was defined as any quantified
biomechanical parameters derived from the SM
force-time profile such as the preload force, the
thrust force, and the duration or rate of force
application.
2) SM frequency was defined as the number of SM
treatment delivered over a given period of time.
To be included, a study had to include within or be-
tween group comparison of different SM dosages or dif-
ferent SM treatment frequencies. The following types of
publication were excluded: practice guidelines, unpub-
lished manuscripts, dissertations, government reports,
books or book chapters, and conference proceedings.
Screening and agreement
We used a 2-phase screening process to select eligible
studies. A pair of reviewers (MP, CD) independently
screened the search results, using an Excel spreadsheet
for both phases. The first phase (I) aimed at determining
the study eligibility using titles and abstracts only. Stud-
ies were then classified as relevant, possibly relevant and
irrelevant. The second phase (II) involved a full-text
screening of the relevant and possibly relevant studies to
identify the final list of articles from which data was ex-
tracted for this review (Fig. 1.). For each of these phases,
a third reviewer (AAM) was asked to solve any disagree-
ment during the consensual screening process.
Step 4: charting the data
In order to extract and sort the data from relevant
studies, a Word table was created; it included the fol-
lowing items: authors and year of publication, study de-
sign, purpose of the study, sample size, treatment
protocol, groups or experimental conditions, outcomes
measures, clinical or physiological effects, and adverse
events. From the papers included in the phase II of the
screening process, three articles were selected to test
the data extraction table. Data extraction was com-
pleted by one investigator (MP) and double-checked by
a second investigator (AL), who was not involved in the
earlier stages of the selection.
Step 5: collating, summarizing and reporting the results
A descriptive analysis was made to detail the search re-
sults including the number of papers kept for analysis,
their year of publication and study design. The summary
of the evidence table was divided into two sections, the
first half being dedicated to the dosage studies and the
second half to the frequency studies. Data for humans
and animals were summarized separately due to the na-
ture of the respective study outcomes. In order to pro-
vide a quality assessment of randomized control trials
(RCT), all frequency studies (six publications) were sub-
mitted to the Cochrane Risk of bias tool [12]. Two as-
sessors (MP and AAM) independently evaluated the
following items: random sequence generation, allocation
concealment, selective reporting, blinding of participants
and personnel, blinding of outcome assessment, incom-
plete outcome data, and other bias. During the assess-
ment of each article, if information related to a specific
item was not available, the item was rated as unclear.
The overall number of high or unclear risk of bias
allowed a final judgment for each paper evaluated. For
dosage studies, quality assessment analysis was not pos-
sible due to the heterogeneity in study design and re-
search questions.
Results were then sorted by themes of interest: “fre-
quency studies” or “dosage studies”. In order to an-
swer our search question, all the pertinent outcomes




A total of 4854 articles were identified from the literature
search. Following the removal of duplicates (n = 954),
3868 papers were excluded and 32 fulfilled the selection
criteria. No article was retrieved from the additional data
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sources. Figure 1 presents the flowchart of studies selec-
tion and inclusion.
Out of the 32 studies included for this scoping review,
22 were experimental studies, seven were RCT, two were
crossover studies, and one was a non-randomized con-
trol trial.
Six studies [13–18] focused on frequency outcomes and
compared the effects of a specific number of SM treat-
ment (from 1 to 18) delivered over a given period of time
(from 3 to 8 weeks). All these studies were randomized
control trials conducted on human participants with ei-
ther cervicogenic headaches [16–18], chronic low back
pain [14, 15] or lumbar spine stenosis [13], with the main
outcomes being self-reported levels of pain and disability.
Duration of treatment varied between 3, 6 or 8 weeks.
Two studies reported post-manipulation outcomes only
whereas four studies also included a 12, 20, 24 or 52-week
follow-up measure.
On the other hand, 26 studies focused on dosage out-
comes where biomechanical parameters derived from
the SM force-time profile were used to set and compare
dosages. Twelve studies involved human participants
[10, 19–29] and 14 were animal-based studies [30–43].
No cadaver studies were included following the study
selection process since they did not meet our inclusion
criteria. Spinal manipulations were delivered in differ-
ent ways including the use of: [1] research-developed
mechanical apparatus (n = 18); [2] manual high-velocity
low-amplitude SM (n = 5); [3] common clinical tools
such as activator or impulse devices (n = 5, 4] manual
mobilizations based on Maitland grades (n = 2, 5]
flexion-distraction table (n = 2).
Fig. 1 Flowchart diagram. CGH: Cervicogenic Headache; LBP: Low back pain; LSS: Lumbar Spinal Stenosis; LDS: Lumbar Decompression Surgery
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The Journal of Manipulative and Physiological Thera-
peutics was the main scientific journal where the SM
treatments frequency and dosage studies were published,
with a total of 15 articles. Figure 2 presents all included
studies based on peer-reviewed publication journals.
Risk of bias assessment for randomized control trials
Seven randomized control trials were assessed for qual-
ity, of which six, reported on the effects of SM frequency
[13–18] including four pilot studies [13, 14, 16, 18] and
one reported on the dosage effects [21]. Four studies
[13, 14, 16, 18] presented a high risk for other bias be-
cause they did not report an a priori sample size calcula-
tion and included between 24 to 80 participants. Five
studies had one or two unclear risks of bias for reasons
related to randomization, blinding of participants and
personnel, or blinding of outcome assessment, which
lowered the confidence in the overall reported effects.
Finally, two studies were rated as having a low risk of
bias [15, 17]. Table 1 summarizes the risk of bias for
each of the RCTs.
Thematical analysis of findings
Frequency studies
Cervicogenic headache Three studies investigated the
effect of the number of SM on cervicogenic headache
(CGH).
A randomized control trial by Haas et al. (2004) (N = 24)
compared three different SM treatment frequencies (1, 3 or
4 times/week) over a 3-week period. Headache-related pain
and disability decreased in people who received a
total of 3 treatments and 4 treatments per week com-
pared to one treatment per week. There was no sig-
nificant between-group difference regarding neck pain
and disability [16].
A randomized control trial from Haas et al. (2010) (N
= 80) compared, over an 8-week period, four groups re-
ceiving either 8 or 16 SM treatments and 8 or 16 light
massage (LM) treatments. Results showed that the two
SM treatment frequencies yielded similar results for
CGH pain and disability. Improvement in pain and dis-
ability were statistically and clinically higher in SM
groups compared to LM. Again, the number of days
with headache episodes decreased significantly more in
SM groups compared to LM groups but no frequency ef-
fect was observed.
A pilot of a randomized control trial from Haas et al.
(2018) (N = 256) compared the effect of different SM
treatment frequency alone and combined with LM over
a 6-week period [17]. The study involved 256 partici-
pants divided into four groups receiving: [1] 0 SM + 18
LM; [2] 6 SM + 12 LM; [3] 12 SM + 6 LM or [4] 18 SM
+ 0 LM. The results showed that the number of days
with cervicogenic headaches decreased for all groups
and that the most significant reduction occurred in 18
SM visits compared to LM. Differences between the
three frequency groups, however, were not statistically
different. There was no significant between-group differ-
ence regarding cervicogenic headache pain intensity and
improvement was only observed for CGH disability of
all 3 SM groups when compared to the control group.
Chronic low back pain Two studies investigated the ef-
fect of treatment frequency in patients with chronic low
back pain.
A pilot study from Haas et al., (2004) compared the
number of SM treatments (alone or combined with
physical modalities) over a 3-week period with a sample
size of 70 participants. Four groups received 1 to 4 treat-
ments per week. Low back pain intensity and associated
Fig. 2 Number of included studies per peer-reviewed journal
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disability were assessed over 12 weeks. Results showed
that there was a significant number of treatment effect
(regardless of the use of physical modalities) regarding
disability. Indeed, compared to baseline, disability im-
proved at 4 and 12 weeks with a higher effect of fre-
quency (3 or 4 SM treatments per week) at 4 weeks
compared to 12 weeks. Regarding pain intensity, higher
treatment frequency led to a decrease in VAS score, at
12 weeks follow-up with results showing a significant
interaction between the type and frequency of treatment.
Results yielded important improvements in pain inten-
sity when SM was associated with physical modalities
and a higher number of treatment (3 or 4 SM treatments
per week) [14].
In a randomized control trial including 400 partici-
pants, the same group investigated the dose-response re-
lationship between the number of SM visits (LM
compared to 1, 2 or 3 SM sessions per week) and clinical
improvements in pain and disability over a 6-week
period. They reported significant differences in out-
comes favoring SM groups; however results showed no
significant differences for pain intensity and disability
between the various SM frequencies [15].
Lumbar spinal stenosis One pilot study involving 60
participants focused on the effects of different
flexion-distraction manipulation frequencies on pain and
symptom severity in patients with lumbar spinal stenosis.
Over a 6-week period, participants received 8, 12, or 18
treatments and were compared to a placebo group (low
level laser therapy and simulated mechanically-assisted
SM). Symptoms severity and disability were assessed up to
6months. Compared to baseline scores, results showed
that symptoms severity was significantly improved at
completion of care and that the effect persisted at 3 and 6
months follow-up in the higher frequency groups (12–18
treatment over 6-week period. The study also reported
that higher frequency of treatments (12–18 treatment over
6-week period) yielded an improvement in disability at 3
months follow-up. Similarly, the group that received 18
treatments showed significant improvements in disability
at the end of care assessment and this difference remained
Table 1 Cochrane Risk of bias tool assessment of randomized control trials
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3months later. Moreover there was no significant between
groups differences for symptom severity, and no compari-
son were presented by the authors for disability. [13].
From all these studies, only one reported adverse event
[17]. Identified adverse events were mostly classified as
were all short term and classified as moderate resulting
from treatment (SM or light massage). Adverse events
related to SM were described as neck soreness, pain,
stiffness, transient upper extremity pain/tingling, in-
creased headache intensity, nausea or dizziness) and oc-
curred in 40% of participants. The proportion of adverse
events was similar for each treatment frequency (1, 2, or
3 SMT per week over a 6-week period).
Dosage studies
The majority of studies (25/26) [10, 19, 20, 22–31, 33–
39, 41–44] reported on the physiological outcomes of
SM and one reported on the clinical outcomes of SM in
a neck pain population [21].
Clinical outcomes in humans One pilot randomized
control trial investigated the effects of three different
manually-delivered cervical traction forces (low, medium
and high) in 48 participants experiencing chronic neck
pain. Results suggest that high-force tractions signifi-
cantly improve neck pain compared to low-force trac-
tions whereas, improvements in disability were
significantly greater for medium and high-force tractions
compared to low-force tractions [21].
Physiological outcomes in humans The most com-
monly reported physiological outcomes were muscular
response’s amplitude (n = 6), vertebral displacement (n =
5), and pain pressure threshold (n = 4). Table 2 summa-
rizes the effects of SM based on outcome categories.
Physiological outcomes in animals The data extraction
highlighted one major outcome described in 7 studies
[30, 35–40]: muscle spindle activity (MSA). All studies
showed that MSA increased with either decreasing
thrust durations, increased applied forces or sometimes
both [35–37]. Detailed results describing changes in
muscle spindle activity and dosage effects are summa-
rized in Table 3.
Other physiological outcomes such as displacements,
acceleration responses and muscle activation (EMGs) re-
sponses were studied using sheep [31, 33, 34]. Colloca et
al. (2006) investigated the effects of varying posterior to
anterior mechanical stimulation force-time profiles on
lumbar spine. Variable durations or amplitudes of stimu-
lation were applied. Descriptive results showed that
EMG responses were higher for thrust duration of 100
ms and 200 ms compared to 10 ms. The displacement
response and vertebral acceleration also increased
linearly with force [31].
Two studies written by Keller et al., reported on accel-
eration responses outcomes [31, 33, 34]. The first one
investigated SM impulses induced by an instrument. Fif-
teen sheep received three different force settings on the
lumbar region. Results highlighted that when increasing
force magnitude, acceleration responses increased in the
3 axes (axial, medio-lateral and posterior-anterior) [33].
The second one, compared three force settings (low,
medium and high forces) of three types of mechanical
instruments simulating SM. Stimulations were applied
on the sheep’s T12 vertebrae. Results showed that accel-
eration responses and vertebral displacement increased
in the 3 axes with increasing forces [34].
One study focused on the effect of SM therapy forces
and durations on cat spine stiffness coefficient. Vaillant
et al. (2012) divided cats into groups receiving a preload
force or not, variable applied forces (ranges established
according to body weight) and movement amplitudes (1,
2 or 3 mm). For each possible combination, eight differ-
ent durations were applied on the lumbar region. Al-
though results showed a complex significant interaction
between duration, force and displacement amplitudes if
SM therapy was preceded by a preload and under dis-
placement control, consistent spinal stiffness modulation
across thrust durations or thrust forces could not be
identified [43].
Finally, in 2014, Reed et al. studied if variable SM
thrust forces could alter mechanical trunk response
thresholds in wide dynamic range and/or nociceptive
specific lateral thalamic neurons [41]. This protocol was
tested on rats’ lumbar spine. Three thrusts were ran-
domly delivered with varying forces magnitudes (0, 55%
or 85% body weight) for 100 ms. Electrophysiological ac-
tivity of wide dynamic range and/or nociceptive specific
lateral thalamic neurons was recorded. Results suggest
that for nociceptive specific lateral thalamic neurons,
dorsal-ventral thrust forces corresponding to 85% body
weight increased mean trunk mechanical threshold com-
pared to the control condition (0% body weight) but not
compared to 55% body weight. There were no significant
differences for wide dynamic range neurons.
Discussion
This scoping review investigated the effect of SM ther-
apy frequency and dosage on clinical and physiological
outcomes. Our main objective was to identify and report
all clinical and physiological outcomes specific to SM
frequency and dosages effects. From all the included ar-
ticles, we were able to establish that most studies fo-
cused on dosage effects (26 dosage studies compared to
6 frequency studies). Fourteen studies involved animals,
while 18 studies were conducted on human participants.
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The most commonly addressed conditions in human
studies were cervicogenic headache followed by low back
pain. Study designs were heterogeneous and involved
clinical and experimental studies. The effects of SM dos-
ages were by far most commonly studied compared to
treatment frequencies. To answer our main research
question, outcomes were categorized into clinical or
physiological outcomes. All human-based clinical trials
investigating the effects of dosage (n = 1) or frequency
(n = 6) included both pain and disability outcomes. On
the other hand, physiological outcomes most commonly
included muscle spindle activity, muscular response
Table 2 Summary of the SM dose-physiological response relationship in human studies. (N=Newton)










Thrust forces: 50, 200 N L5 N = 30 ● NO DIFFERENCES




Thrust durations: 30s,60s L3 N = 19 ● NO DIFFERENCES
[29] Willett
et al, 2010
Thrust durations: 1 Hz, 2 Hz L1 to L3 N = 30 ● NO DIFFERENCES
[19] Colloca
et al, 2003
Thrust forces: 30 N, 150 N L1 to L3 N = 4 MUSCULAR
RESPONSE
AMPLITUDE





Thrust forces: 19,5 N,190 N Bilateral PSIS, sacrum,
S1 and L5, L4, L2, T12
and T8
N = 40 ● Increase after SM treatment
● SMT showed a greater
increasing than control
group and sham treatment
[25] Nougarou
et al, 2014
Preload forces: 5 N,50 N, 95 N,
140 N
T6 to T8 N = 23 ● Decrease during preload
● Increase during thrust
[26] Nougarou
et al, 2016
Combination of thrust forces
/ thrust durations: 57 ms/150 N,
80 ms/200 N, 102 ms,250 N, 125
ms/300 N
T6 to T8 N = 25 ● NO DIFFERENCES
[24] Nougarou
et al, 2013




Thrust forces: 75 N,125 N,175 N,
225 N




Thrust forces: 30 N, 150 N L1 to L3 N = 4 VERTEBRAL
DISPLACEMENT
● Data suggest an increase
when greater force is applied
[20] Colloca
et al, 2004
Thrust forces: 30 N, 88 N, 117 N,
150 N




Thrust forces: 19,5 N,190 N Bilateral PSIS, sacrum,
S1 and L5, L4, L2, T12
and T8
N = 40 ●increase after any treatment
●SMT showed a greater
increasing than control
group and sham treatment
[25] Nougarou
et al, 2014
Preload forces: 5 N,50 N, 95 N,
140 N
T6 to T8 N = 23 ●Linear decrease with force
during thrust phase




Combination of thrust forces /
thrust durations: 57 ms/150 N,
80 ms/200 N, 102 ms,250 N,
125 ms/300 N
T6 to T8 N = 25 ● Increase in thrust phase
with increasing thrust force
[27] Pagé
et al, 2014
Thrust durations: 125 ms,
175 ms, 275 ms
T7,T8 N = 20 ● NO DIFFERENCES
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activity, vertebral displacement, pain pressure threshold
and acceleration responses. Based on the studies in-
cluded in this review, none of the human studies investi-
gated the relationship between physiological outcomes
and clinical outcomes.
Frequency effects
In order to appreciate the clinical relevance of frequency
effects, results should be interpreted considering the mini-
mum clinically important difference (MCID) for pain and
disability outcomes. Although three studies reported sta-
tistically significant frequency effects [15, 17, 45], only two
studies described their results using clinically meaningful
thresholds [15]. Indeed, only two RCT (Haas et al., 2014
[15] and 2018 [17]) reported clinically relevant effects, but
these effects were present only when SM was compared
to the control group (not or for frequency effects). These
two studies showed that compared to no treatment or
light massage, SM therapy had durable benefits for neuro-
musculoskeletal disorders-related pain and/or disability if
the treatment is repeated over a period of time. When fre-
quency effects are considered for patients with back pain
or headache, trends in improvement were observed and
indicated that increasing the number of SM visits in a
short period of time (few weeks) decreased pain and im-
prove disability as well as reducing the number of days
with headaches episodes.
Dosage effects
Four studies involving human participants showed that
vertebral displacement and muscular amplitude re-
sponses increased when higher SM forces were applied
Table 3 Summary of the SM dose-physiological response relationship in animal studies
Studies Dosage parameters Sample size Spine
level
Muscle spindle activity - main results
[30] Cao et al., 2013 Thrust forces: 25, 55, 85% of BW n = 112 cats L6 ● Consistent increase in MIF for 1 mm thrust
amplitude.
Thrust displacements: 1, 2 or 3 mm ●No specific trend associated to modulation in
forces and displacements
Thrust durations: 0,25,50,75,100,150,200, 250 ms
[35] Pickar et al., 2006 Thrust forces: 33, 66, 100% of BW n = 46 cats L6 ●Data suggest that decreasing thrust duration
increases ΔMIF
Thrust duration: 25, 50, 100, 200, 400 or 800 ms ● There is a threshold effect for duration for
which the discharge greatly increases
[36] Pickar et al., 2007 Thrust displacement: 1 or 2 mm n = 54 cats L6 ● Data suggest that decreasing thrust duration
increases ΔMIF
Thrust duration: 12.5, 25, 50, 100, 200, 400 ms
● Peak thrust amplitude (1 mm compared to
2 mm) influence ΔMIF
[37] Reed et al., 2013 Thrust forces: 25, 55, 85% of BW n = 112 cats L6 ● Data suggest that decreasing thrust duration
increases mean spindle discharge through range
of forces.
Thrust displacement: 1, 2 or 3 mm ● Through a range of force durations, increasing
force seems to increase ΔMIF.
Thrust durations: 25, 50, 75, 100, 200, 250 ms ● For most thrust duration, peak thrust
displacement did not influence ΔMIF.
● Increasing force rates increased MIF
[38] Reed et al., 2015 Thrust force: ranges from 68 N to 122 N n = 1 cat L7 ● Data suggest that increasing force leads to
increase ΔMIF.
[39] Reed et al., 2014 Preload variation: 18% or 43% of thrust force n = 20 cats L6 ● Increasing longer preload duration (4 s
compared to 1 s) increases ΔMIF.
Thrust durations: 1 or 4 s (Thrust force: 55%
of BW) ● A smaller magnitude of preload (18%
compared to 43%) increases ΔMIF
● The highest preload magnitude and longest
duration led to a significantly greater mean
decrease in resting spindle discharge
[40] Reed et al., 2017 Thrust force: 22 N, 44 N or 67 N n = 6 cats L6 ● Data suggest that increase in force increased
the time required until the first action potential.
MIF Mean Instantaneous Frequency, ΔMIF Changes in Mean Instantaneous Frequency, BW body of weight
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whereas modulation of SM dosage did not seem to mod-
ify pain pressure thresholds. Despite consistent changes
in physiological responses due to dosage effects, the as-
sociation between these changes and clinical outcomes
remains unknown. Only one paper investigated the ef-
fect of dosage on clinical outcomes and showed an im-
provement in pain and disability when medium or high
force tractions were applied (compared to low force trac-
tion). However, the high risk of bias (Table 1) identified
for this specific RCT refrains us from any definitive con-
clusion with regard to SM dosages and clinical
outcomes.
Five studies focusing on muscle spindle discharge in
animals consistently reported an increased mean fre-
quency discharge when higher thrust forces were ap-
plied; and similar trends were seen for shorter thrust
duration [30, 35–37, 39, 40, 46]. Muscle amplitude re-
sponse assessed with EMGs was studied in one animal
study and showed increased EMG response amplitudes
when higher forces and longer thrust durations were ap-
plied [31]. Although animal models may have similar
biomechanical properties with humans, anatomical fac-
tors (geometry and morphology) as well as loading char-
acteristics of spinal structure are known to differ
between such models and human spine [34]. A few stud-
ies attempted to reproduce a range of forces similar to
clinically relevant SM in humans but the relative “clin-
ical relevance” of the SM characteristics used in animal
models was often reported as one of the challenges in
data interpretation [39, 41]. Moreover, the use of differ-
ent anaesthetics may have altered muscle function differ-
ently and again may have limited the generalization and
interpretation of SM dosage effect studied in animal
models. Animal studies provide valuable information
when invasive procedures are needed and, for ethical
reasons not possible in humans. Results, however,
should be interpreted with caution, as they may not al-
ways reflect SM characteristics and effects in humans.
Limitations
The first limitation that should be considered is the various
operational definitions used for spinal manipulation dosage
and frequency in the original studies. Some studies may
have been missed or excluded due to the lack of consensus
with regard to these definitions. A recent paper by Groene-
weg et al. recommended a list of criteria to standardize the
reporting of SM intervention [47]. Indeed, some studies did
not use the definition described in our method for dosage
and frequency terms in the same definition as described in
our method. Although the authors proposed a clear defin-
ition for frequency, the definition for dosage remains am-
biguous and seems to encompass time spent in therapy by
the patient and efforts expended by the therapist during
treatment sessions, two elements that seem to be related to
overall care dosage rather than specific SM parameters
[47]. Moreover, some of the clinical trials may have been
underpowered as only two clinical studies adequately re-
ported sample size determination. Lack of power in clinical
studies may have led to inconsistent and sometimes mis-
leading results and interpretations.
In addition, a comparison between studies could not be
performed due to heterogeneity of SM uses across studies.
In some studies, lack of SM standardization between condi-
tions or groups within a given study may have been an issue
[23, 29]. Finally, for 23 dosage studies, SM was delivered by
a mechanical device simulating SM for which dosages were
quantified. Although these devices were, in a few instances,
designed to simulate clinician’s SM performance. Such de-
vice may not reflect the manual SM or mobilization most
commonly performed by clinicians. According to Beliveau,
only 23% (Interquartile range: 14.0–38.0) of chiropractor
use instrumented assisted SM compared to 79% of chiro-
practors using manual SM [7].
Research recommendations
Considering the high heterogeneity of the included studies
regarding design, populations, conditions, outcomes and
SM delivery (manual or mechanically assisted), it was not
possible to determine optimal dosages and frequencies for
the treatment of spinal conditions. As previously recom-
mended future studies should provide detailed informa-
tion with regards to SM, including treatment frequency
and dosage. When possible, SM dosages should be de-
scribed using treatment characteristics derived from the
force-time profile. Several studies investigating SM motor
control and learning have used force-sensing technologies
to quantify SM biomechanical parameters [48, 49]. Such
technologies should be considered in clinical trials evalu-
ating not only dosage and frequency effect, but also in any
study investigating clinical effects of manual therapy. The
true dose-response relationship between SM biomechan-
ical parameters and clinical outcomes could then be
investigated.
Conclusion
The results of this study showed that SM dosage and fre-
quency effects have been mostly studied over the past two
decades. Definitions for these two concepts are, however,
heterogeneous across studies. Based on limited evidence,
results suggest that treatment frequency does not signifi-
cantly impact clinical outcomes during and following SM
treatment period. However, additional work is likely to
modify the current state of knowledge and a definitive con-
clusion at this time would be untimely. Dosage effects
clearly influence short term physiological responses to SM
treatment, but the relationship between these responses
and clinical outcomes remains to be elucidated.
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